Penn Medicine to deploy precision medicine to study Parkinson's

Penn Medicine has launched the "Molecular Integration in Neurological Diagnosis Initiative," which will use genetic and molecular profiling to better understand ways to detect and treat Parkinson's disease.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.